Anxiety and depression in patients with malignant tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed as malignant tumors by imaging or pathology (such as hepatobiliary carcinoma, gastric cancer, breast cancer, lung cancer, etc.); 2. Planning to receive or currently undergoing systemic treatment (such as surgery, chemotherapy, TACE, targeted therapy, etc.); 3. Age >=18 years old; 4. Sign the informed consent form and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1. Combined with severe systemic diseases (such as severe cardiovascular and cerebrovascular diseases); 2. There is severe cognitive impairment and it is impossible to complete the questionnaire assessment; 3. Incomplete clinical data or loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective Response Rate (ORR) by mRECIST (%); | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life (EORTC QLQ-C30);anxiety;Overall Survival;depression;Hamilton Scale;Progression free survival;Treatment Adherence; | — |
Countries
China
Contacts
The First Affiliated Hospital of Wenzhou Medical University